Table 9.9b

Unadjusted Graft Survival, Living Donor Liver Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

  3 Months 1 Year 3 Years 5 Years
(Tx 2002 - 2003) (Tx 2002 - 2003) (Tx 2000 - 2003) (Tx 1998 - 2003)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 679 87.6% 1.3% 679 81.7% 1.5% 1,586 73.2% 1.2% 1,928 69.7% 1.2%
Primary Diagnosis Non-Cholestatic Cirrhosis 337 89.6% 1.7% 337 82.5% 2.1% 798 72.6% 1.7% 915 68.7% 2.1%
Cholestatic Liver Disease/Cirrhosis 137 91.2% 2.4% 137 88.3% 2.7% 285 78.2% 2.6% 315 73.0% 3.3%
Acute Hepatic Necrosis 35 74.3% 7.4% 35 68.6% 7.8% 84 66.2% 5.2% 114 67.3% 4.4%
Biliary Atresia 72 88.9% 3.7% 72 87.5% 3.9% 170 80.2% 3.2% 258 77.0% 2.9%
Metabolic Diseases 15 80.0% 10.3% 15 66.7% 12.2% 47 64.1% 7.4% 65 64.2% 6.3%
Malignant Neoplasms 28 78.6% 7.8% 28 60.7% 9.2% 85 57.9% 5.6% 109 51.8% 5.3%
Other 54 81.5% 5.3% 54 77.8% 5.7% 116 77.3% 4.1% 151 72.6% 4.1%
Unknown 1 0.0% 0.0% 1 0.0% 0.0% 1 0.0% 0.0% 1 0.0% 0.0%


Source: OPTN/SRTR Data as of May 2, 2005.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on liver transplants.

Multi-organ transplants are excluded.